FDA Biologics (BLA & Biosimilars)Original article
Vaccines and Related Biological Products Advisory Committee October 1, 2026 Meeting Announcement - 10/01/2026
AdComInfluenza virus vaccinesNeutral
AI Analysis
Summary
The FDA's Vaccines and Related Biological Products Advisory Committee is scheduled to meet on October 1, 2026 to discuss and provide recommendations on strain selection for influenza virus vaccines for the 2027 Southern Hemisphere influenza season.
Outcome Details
Committee to discuss strain selection for influenza vaccines for 2027 Southern Hemisphere season
Importance:3/10
Sentiment:
0.00
FDA Advisory CommitteeInfluenza vaccinesStrain selection2027 Southern Hemisphere
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 18, 2026 2:11 PM